Brief: Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting clinical Results Of AD04 As A Potential Treatment For Alcohol Use Disorder

Azora Therapeutics

10/04/2024 13:51

April 10 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS ANNOUNCES PEER-REVIEWED PUBLICATION
HIGHLIGHTING  PROMISING SAFETY DATA AND HIGH PATIENT COMPLIANCE
IN A CLINICAL TRIAL OF AD04  AS A POTENTIAL TREATMENT FOR
ALCOHOL USE DISORDER

Source text for Eikon:  ID:nGNX9qFBhr 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))